南美洲和中美洲神经调节市场预测至 2027 年 - COVID-19 影响和区域技术分析（外部（非侵入性）神经调节和内部神经调节）；应用（慢性疼痛管理、腰背综合症、癫痫、震颤、失禁、抑郁症、肌张力障碍、胃轻瘫、帕金森病、强迫症和偏头痛）；最终用户（医院、诊所和家庭医疗保健）和国家/地区
No. of Pages: 186 | Report Code: TIPRE00016290 | Category: Life Sciences
No. of Pages: 186 | Report Code: TIPRE00016290 | Category: Life Sciences
神经调节是通过控制神经递质的生理水平来调节神经活动的过程。这些改变是在各种设备的帮助下或通过药物输注实现的。这些设备包含放置在脊髓、大脑或周围神经上的小电极。脑血管疾病、阿尔茨海默病和帕金森病等神经系统疾病会影响身体的神经功能，因此可以借助神经调节来治疗。
在南部和南部地区中美洲，神经调节市场预计将从2019年的3.1672亿美元增至2027年的6.2722亿美元；预计 2020 年至 2027 年该市场将以 9.2% 的复合年增长率增长。市场的增长归因于市场上产品的增加、神经调节设备产品创新的不断增加以及神经调节技术的不断发展。然而，神经调节设备的高成本可能会限制预测年内市场的增长。
在技术方面，预计到2027年，外部（非侵入式）神经调节领域将占据神经调节市场的最大份额。在应用方面，慢性疼痛管理占据了主导地位。神经调节市场中最重要的市场份额。从终端用户来看，预计到2027年，医院细分市场仍将保持最大市场份额
报告中包含的神经调节市场的一些主要一手和二手来源包括心理健康数据库、神经系统疾病数据库、阿尔茨海默病网站等.
· ; 外部（非侵入性）神经调节
o 呼吸电刺激 (RES)
o 经皮神经电刺激 (TENS)
o 经颅磁刺激（TMS）
· 内部神经调节
o 深部脑刺激（DBS）
o 骶神经刺激（SNS）
o 胃电刺激 (GES)
o 脊髓刺激（SCS）
o 迷走神经刺激（VNS）
· 慢性疼痛管理
· 失败恢复综合症
· 癫痫
· 震颤
· 失禁
· 抑郁症
· 肌张力障碍
· 胃轻瘫
· 帕金森病
· 强迫症
· 偏头痛
· 医院
· 诊所
· ; 阿联酋
· 沙特阿拉伯
· 南非
Strategic insights for South and Central America Neuromodulation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 316.72 Million |
| Market Size by 2027 | US$ 627.22 Million |
| Global CAGR (2020 - 2027) | 9.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America Neuromodulation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - South & Central America Neuromodulation Market
The South and Central America Neuromodulation Market is valued at US$ 316.72 Million in 2019, it is projected to reach US$ 627.22 Million by 2027.
As per our report South and Central America Neuromodulation Market, the market size is valued at US$ 316.72 Million in 2019, projecting it to reach US$ 627.22 Million by 2027. This translates to a CAGR of approximately 9.2% during the forecast period.
The South and Central America Neuromodulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Neuromodulation Market report:
The South and Central America Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Neuromodulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Neuromodulation Market
